Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies.

Amin A.

Clin Interv Aging. 2013;8:75-84. doi: 10.2147/CIA.S37818. Epub 2013 Jan 22. Review.

2.

An update on antithrombotic therapy in atrial fibrillation: the role of newer and emergent drugs.

Deedwania P, Huang GW.

Rev Cardiovasc Med. 2012;13(2-3):e89-104. Review.

PMID:
23160166
3.

New pharmacologic approaches to prevent thromboembolism in patients with atrial fibrillation.

Hammwöhner M, D'Alessandro A, Wolfram O, Goette A.

Curr Vasc Pharmacol. 2007 Jul;5(3):211-9. Review.

PMID:
17627564
4.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.

Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Review.

PMID:
22684583
5.

[Atrial fibrillation and stroke].

Mattle HP, Schwerzmann M, Seiler Ch.

Ther Umsch. 2003 Sep;60(9):527-34. Review. German.

PMID:
14579621
6.

Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.

van Nieuwenhuizen KM, van der Worp HB, Algra A, Kappelle LJ, Rinkel GJ, van Gelder IC, Schutgens RE, Klijn CJ; APACHE-AF Investigators..

Trials. 2015 Sep 4;16:393. doi: 10.1186/s13063-015-0898-4.

7.

[Atrial fibrillation and thromboembolic events prevention. State of the art].

Matteoli S, Trappolini M, Chillotti FM.

Minerva Cardioangiol. 2001 Feb;49(1):1-13. Review. Italian.

PMID:
11279381
8.

[Preventing cerebrovascular accidents during atrial fibrillation].

Ederhy S, Meuleman C, Hammoudi N, Janower S, Boccara F, Cohen A.

Presse Med. 2005 Oct 22;34(18):1315-24. Review. French.

PMID:
16269996
9.

Oral anticoagulants for Asian patients with atrial fibrillation.

Sabir I, Khavandi K, Brownrigg J, Camm AJ.

Nat Rev Cardiol. 2014 May;11(5):290-303. doi: 10.1038/nrcardio.2014.22. Epub 2014 Mar 11. Review. Erratum in: Nat Rev Cardiol. 2014 Dec;11(12):686.

PMID:
24614113
10.
11.

Recent advances in antithrombotic therapy for stroke prevention in patients with atrial fibrillation.

Lenchus JD.

Hosp Pract (1995). 2013 Feb;41(1):49-60. doi: 10.3810/hp.2013.02.1007.

PMID:
23466967
12.

Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.

Lane DA, Raichand S, Moore D, Connock M, Fry-Smith A, Fitzmaurice DA; Steering Committee..

Health Technol Assess. 2013 Jul;17(30):1-188. doi: 10.3310/hta17300. Review.

13.

Antithrombotics in atrial fibrillation and coronary disease.

Velagapudi P, Turagam MK, Agrawal H, Mittal M, Kocheril AG, Aggarwal K.

Expert Rev Cardiovasc Ther. 2014 Aug;12(8):977-86. doi: 10.1586/14779072.2014.937427. Review.

PMID:
25046150
14.

Oral anticoagulants to reduce the risk of stroke in atrial fibrillation: how should a clinician choose?

Mohammed I, Syed W, Kowey PR.

Clin Cardiol. 2013 Nov;36(11):663-70. doi: 10.1002/clc.22173. Epub 2013 Jul 24. Review.

15.

What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation?

Lip GY.

J R Coll Physicians Edinb. 2012;42 Suppl 18:35-44. doi: 10.4997/JRCPE.2012.S04.

PMID:
22518392
16.
17.

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.

van Walraven C, Hart RG, Singer DE, Laupacis A, Connolly S, Petersen P, Koudstaal PJ, Chang Y, Hellemons B.

JAMA. 2002 Nov 20;288(19):2441-8.

PMID:
12435257
18.

Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial.

Sambola A, Montoro JB, Del Blanco BG, Llavero N, Barrabés JA, Alfonso F, Bueno H, Cequier A, Serra A, Zueco J, Sabaté M, Rodríguez-Leor O, García-Dorado D.

Am Heart J. 2013 Oct;166(4):669-75. doi: 10.1016/j.ahj.2013.07.028. Epub 2013 Sep 14.

PMID:
24093846
19.

Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety.

Salim I, Al Suwaidi J, Ghadban W, Salam AM.

Expert Opin Drug Saf. 2013 Jan;12(1):53-63. doi: 10.1517/14740338.2013.732569. Epub 2012 Oct 24. Review.

PMID:
23095103
20.

Novel oral anticoagulants to prevent stroke in atrial fibrillation.

Verheugt FW.

Nat Rev Cardiol. 2010 Mar;7(3):149-54. doi: 10.1038/nrcardio.2009.235. Review.

PMID:
20179722

Supplemental Content

Support Center